Double-stranded RNA induces biphasic STAT1 phosphorylation by both type I interferon (IFN)-dependent and type I IFN-independent pathways

Journal of Virology

Volumn 86, Issue 23, 2012, Pages 12760-12769

  Dempoya, Junichi ^a   Matsumiya, Tomoh ^a   Imaizumi, Tadaatsu ^a   Hayakari, Ryo ^a   Xing, Fei ^a   Yoshida, Hidemi ^a   Okumura, Ken ^a   Satoh, Kei ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSOL RECEPTOR; DOUBLE STRANDED RNA; INTERFERON; INTERFERON RECEPTOR; MELANOMA DIFFERENTIATION ASSOCIATED GREEN 5 PROTEIN; NEUTRALIZING ANTIBODY; POLYINOSINIC POLYCYTIDYLIC ACID; RETINOIC ACID INDUCIBLE PROTEIN I; RNA; STAT1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOSOL; GENE INDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNITY, INNATE; IMMUNOBLOTTING; INTERFERON TYPE I; INTERFERON-BETA; MICRORNAS; OLIGONUCLEOTIDES; PHOSPHORYLATION; POLY I-C; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA VIRUS INFECTIONS; RNA, DOUBLE-STRANDED; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR;

EID: 84869217775     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01881-12     Document Type: Article

References (51)

1. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor Nature 413, 732-738.
2. Bhattacharyya S, Zhao Y, Kay TW, Muglia LJ. 2011. Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation. Proc. Natl. Acad. Sci. U. S. A. 108, 9554, 9559.
3. Bromberg JF, Fan Z, Brown C, Mendelsohn J, Darnell JE, Jr. 1998. Epidermal growth factor-induced growth inhibition requires Stat1 activation. Cell Growth Differ. 9, 505-512.
4. Cheriyath V, et al. 2007. G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells. J. Clin. Investig. 117, 3107-3117.
5. Cui S, et al. 2008. The C-terminal regulatory domain is the RNA 5=-triphosphate sensor of RIG-I. Mol. Cell 29:169-179.
6. Darnell JE, Jr. 1997. STATs and gene regulation. Science 277, 1630, 1635.
7. Drummond RA, Saijo S, Iwakura Y, Brown GD. 2011. The role of Syk/CARD9 coupled C-type lectins in antifungal immunity. Eur. J. Immunol. 41, 276, 281.
8. Dupuis S, et al. 2003. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33, 388, 391.
9. Fredericksen BL, Keller BC, Fornek J, Katze MG, Gale M, Jr. 2008. Establishment and maintenance of the innate antiviral response to West Nile virus involves both RIG-I and MDA5 signaling through IPS-1. J. Virol. 82, 609-616.
10. Hovanessian AG, Justesen J. 2007. The human 2'-5'oligoadenylate synthetase family, unique interferon-inducible enzymes catalyzing 2'-5' instead of 3'-5' phosphodiester bond formation. Biochimie 89, 779, 788.
11. Imaizumi T, et al. 2005. Involvement of retinoic acid-inducible gene-I in the IFN-γ/STAT1 signalling pathway in BEAS-2B cells. Eur. Respir. J. 25, 1077-1083.
12. Imaizumi T, et al. 2011. Polyinosinic-polycytidylic acid induces the expression of interferon-stimulated gene 20 in mesangial cells. Nephron Exp. Nephrol. 119, e40-e48.
13. Inohara N, Nunez G. 2003. NODs, intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 3, 371-382.
14. Jiang LJ, et al. 2011. RA-inducible gene-I induction augments STAT1 activation to inhibit leukemia cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 108, 1897-1902.
15. Johnsen IB, Nguyen TT, Bergstroem B, Fitzgerald KA, Anthonsen MW. 2009. The tyrosine kinase c-Src enhances RIG-I (retinoic acid-inducible gene I)-elicited antiviral signaling. J. Biol. Chem. 284, 19122-19131.
16. Kato H, et al. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23, 19, 28.
17. Kato H, et al. 2008. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med. 205, 1601-1610.
18. Kato H, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101-105.
19. Kawai T, Akira S. 2006. Innate immune recognition of viral infection. Nat. Immunol. 7, 131-137.
20. Kawai T, et al. 2005. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat. Immunol. 6, 981-988.
21. Kotenko SV, et al. 2003. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4, 69, 77.
22. Kramer OH, et al. 2006. Acetylation of Stat1 modulates NF-kappaB activity. Genes Dev. 20, 473-485.
23. Kumar H, Kawai T, Akira S. 2009. Toll-like receptors and innate immunity. Biochem. Biophys. Res. Commun. 388, 621-625.
24. Lee MS, Min YJ. 2007. Signaling pathways downstream of patternrecognition receptors and their cross talk. Annu. Rev. Biochem. 76, 447-480.
25. Liu SY, Sanchez DJ, Cheng G. 2011. New developments in the induction and antiviral effectors of type I interferon. Curr. Opin. Immunol. 23, 57-64.
26. Liu T, et al. 2004. Reactive oxygen species mediate virus-induced STAT activation, role of tyrosine phosphatases. J. Biol. Chem. 279, 2461-2469.
27. Lutfalla G, et al. 1995. Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. EMBO J. 14, 5100, 5108.
28. Matikainen S, et al. 2000. Influenza A and Sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages. Virology 276, 138, 147.
29. Matikainen S, et al. 2006. Tumor necrosis factor alpha enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression. J. Virol. 80, 3515-3522.
30. Matsumiya T, Imaizumi T, Yoshida H, Satoh K. 2011. Antiviral signaling through retinoic acid-inducible gene-I-like receptors. Arch. Immunol. Ther. Exp. 59, 41-48.
31. Matsumiya T, et al. 2009. The levels of retinoic acid-inducible gene I are regulated by heat shock protein 90-alpha. J. Immunol. 182, 2717-2725.
32. Matsumiya T, et al. 2010. Characterization of synergistic induction of CX3CL1/fractalkine by TNF-alpha and IFN-gamma in vascular endothelial cells, an essential role for TNF-alpha in post-transcriptional regulation of CX3CL1. J. Immunol. 184, 4205-4214.
33. Matsumiya T, Stafforini DM. 2010. Function and regulation of retinoic acid-inducible gene-I. Crit. Rev. Immunol. 30, 489, 513.
34. Melchjorsen J, et al. 2009. Differential regulation of the OASL and OAS1 genes in response to viral infections. J. Interferon Cytokine Res. 29, 199-207.
35. Meraz MA, et al. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84, 431-442.
36. Meylan E, et al. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167-1172.
37. Pavlovic, J, Schroder A, Blank A, Pitossi F, Staeheli P. 1993. Mx proteins, GTPases involved in the interferon-induced antiviral state. Ciba Found. Symp. 176, 233-247.
38. Perry AK, Chow EK, Goodnough JB, Yeh WC, Cheng G. 2004. Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. J. Exp. Med. 199, 1651-1658.
39. Pfeffer LM, et al. 1998. Biological properties of recombinant alphainterferons, 40th anniversary of the discovery of interferons. Cancer Res. 58, 2489, 2499.
40. Platanias LC. 2005. Mechanisms of type-I-and type-II-interferonmediated signalling. Nat. Rev. Immunol. 5, 375-386.
41. Sanz E, Hofer MJ, Unzeta M, Campbell IL. 2008. Minimal role for STAT1 in interleukin-6 signaling and actions in the murine brain. Glia 56, 190, 199.
42. Sartono E, et al. 1995. Elevated cellular immune responses and interferongammarelease after long-term diethylcarbamazine treatment of patients with human lymphatic filariasis. J. Infect. Dis. 171, 1683-1687.
43. Schindler C, Darnell JE, Jr. 1995. Transcriptional responses to polypeptide ligands, the JAK-STAT pathway. Annu. Rev. Biochem. 64, 621-651.
44. Sen GC, Ransohoff RM. 1993. Interferon-induced antiviral actions and their regulation. Adv. Virus Res. 42, 57-102.
45. Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122, 669-682.
46. Sironi JJ, Ouchi T. 2004. STAT1-induced apoptosis is mediated by caspases 2, 3, and 7. J. Biol. Chem. 279, 4066-4074.
47. Tanabe M, et al. 2003. Mechanism of up-regulation of human Toll-like receptor 3 secondary to infection of measles virus-attenuated strains. Biochem. Biophys. Res. Commun. 311, 39-48.
48. Tang L, Roberts PC, Kraniak JM, Li Q, Tainsky MA. 2006. Stat1 expression is not sufficient to regulate the interferon signaling pathway in cellular immortalization. J. Interferon Cytokine Res. 26, 14, 26.
49. Wang H, et al. 2010. STAT1 activation regulates proliferation and differentiation of renal progenitors. Cell Signal. 22, 1717-1726.
50. Xu LG, et al. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19, 727-740.
51. Yoneyama M, et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5, 730, 737.